These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 444298)

  • 1. A structure--activity study of seven new water soluble nitrosoureas.
    Heal JM; Fox P; Schein PS
    Biochem Pharmacol; 1979 Apr; 28(8):1301-6. PubMed ID: 444298
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract]   [Full Text] [Related]  

  • 3. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and antitumor activity of water-soluble (2-chloroethyl)nitrosoureas.
    Suami T; Tadano K; Bradner WT
    J Med Chem; 1979 Mar; 22(3):314-6. PubMed ID: 423215
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP; Montgomery JA
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
    J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (2-Chloroethyl)nitrosourea congeners of amino acid amides.
    Suami T; Kato T; Takino H; Hisamatsu T
    J Med Chem; 1982 Jul; 25(7):829-32. PubMed ID: 7108898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activities of antitumor agents.
    Suami T; Machinami T; Hisamatsu T
    J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different sensitivities of rat ascites hepatoma AH13 and mouse lymphoid leukemia L1210 cells to typical N-nitrosoureas.
    Miyahara M; Sueyoshi S; Kamiya S
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):188-93. PubMed ID: 3698127
    [No Abstract]   [Full Text] [Related]  

  • 10. Noval antitumor nitrosoureas and related compounds and their reactions with DNA.
    Lown JW; Joshua AV; McLaughlin LW
    J Med Chem; 1980 Jul; 23(7):798-805. PubMed ID: 7401107
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in the biochemical pharmacology of selected alkylating agents.
    Wheeler GP
    Transplant Proc; 1973 Sep; 5(3):1167-70. PubMed ID: 4738047
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles.
    Hansch C; Smith N; Engle R; Wood H
    Cancer Chemother Rep; 1972 Aug; 56(4):443-56. PubMed ID: 5081587
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
    Hayat M; Bourut C; Chenu E; Montero JL; Imbach JL; MacDonald JS; Mathé G
    Cancer Chemother Pharmacol; 1979; 3(4):217-21. PubMed ID: 161207
    [No Abstract]   [Full Text] [Related]  

  • 14. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
    Carter SK; Schabel FM; Broder LE; Johnston TP
    Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
    Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
    Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars.
    Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A
    J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results.
    Madelmont JC; Godeneche D; Parry D; Duprat J; Chabard JL; Plagne R; Mathe G; Meyniel G
    J Med Chem; 1985 Sep; 28(9):1346-50. PubMed ID: 4032435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.